Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03548779Not ApplicableCompleted

North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

Role: collaborator

NCT06424119Not ApplicableRecruiting

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

Role: collaborator

NCT05874661Not ApplicableUnknown

FOA on Sit to Stand in Individuals Post Stroke

Role: collaborator

NCT04696302Not ApplicableCompleted

Focus of Attention in Individuals With Stroke

Role: collaborator

NCT03204851Not ApplicableUnknown

Microlyte Dressing in the Management of Wounds

Role: lead

All 5 trials loaded